Recent Updates
Recently added Catalysts
MEDP Positive Sentiment Score: 75/100

Medpace Holdings, Inc. Reports Second Quarter 2026 Results

Wednesday, July 22, 2026 1 min read
Key Takeaway: Medpace Holdings, Inc. reported a significant revenue increase of 17.2% for the second quarter of 2026, reaching $707.3 million compared to $603.3 million in the same period last year. This growth was consistent even when adjusted for currency fluctuations. The company continues to show strong financial performance.

Market Sentiment Analysis

POSITIVE FACTORS

  • Revenue increased by 17.2% year-over-year.
  • Total revenue reached $707.3 million.
  • Strong performance on a constant currency basis.

Full Press Release Details

CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the second quarter ended June 30, 2026. Second Quarter 2026 Financial Results Revenue for the three months ended June 30, 2026 increased 17.2% to $707.3 million, compared to $603.3 million for the comparable prior-year period. On a constant currency basis, revenue for the second quarter of 2026 increased 17.2% compared to the second quarter of 2025. Backlog as of June 30, 2026 in

Frequently Asked Questions

What was Medpace's revenue for Q2 2026?

Medpace's revenue for Q2 2026 was $707.3 million.

How much did revenue increase year-over-year?

Revenue increased by 17.2% compared to Q2 2025.

What was the revenue for Q2 2025?

The revenue for Q2 2025 was $603.3 million.

Was the revenue growth affected by currency fluctuations?

No, the revenue growth was consistent on a constant currency basis.

Tags: MEDP Viatris Investor Conferences Healthcare Medpace Q2 2026 revenue growth financial results
Last updated: Jul 22, 2026

Biotech snapshot

Cash runway
$497M liquidity · $0M/mo burn
Low dilution risk